BREAST CANCER DETECTION WITH 99M TC MIBI IMAGING AND MAMMOGRAPHY

Authors

  • Tawatchai CHAIWATANARAT Department of Radiology, Faculty of Medicine, Chulalongkorn University
  • Chalermchai APINYANURAK Department of Radiology, Faculty of Medicine, Khon Kaen University
  • Darunee BOONJUNWETWAT Department of Radiology, Faculty of Medicine, Chulalongkorn University
  • Kris CHATAMRA Department of Surgery, Faculty of Medicine, Chulalongkorn University
  • Makumkrong POSHYACHINDA Department of Radiology, Faculty of Medicine, Chulalongkorn University

Abstract

Screening mammography in female patients provides good sensitivity in the detection of breast abnormalities but low specificity for the diagnosis of breast carcinoma. Thus many patients end up with unnecessary biopsy and/or lumpectomy. The use of nuclear medicine methods in detection of malignancy has been wildly studied with various radiopharmaceuticals. The objective of this study was to study the efficacy 99mTcMIBI scintimammography and mammography in the detection of breast carcinoma. The diagnosis would be made by pathological findings of the tissue or clinical follow up for at least 6 months. There were 33 female patients included in the study, among these there were 7 cases with known carcinoma of breast and clinically suspected of recurrent. Of all 33 cases, 14 cases was diagnosed as breast carcinoma and 19 cases as benign disease of the breasts. The results showed that sensitivity, specificity, accuracy, positive predictive value and negative predictive value of99mTc-MIBI scintimammography in the diagnosis of breast carcinoma were 93%, 100%, 97%, 100% and 95% respectively. Sensitivity, specificity, accuracy, positive predictive value and negative predictive value of mammography were 100%, 63%, 79%, 67% and 100% respectively. We concluded that99mTc-MIBI scintimammography has a good efficacy and increase specificity of mammography in the diagnosis of breast carcinoma. We suggested that patients should have mammography performed first, if the lesion is indeterminated by mammography then99mTc-MIBI scintimammography will be the next step for investigation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Vatanasapt V, Martin N, Sriplung H, Chindavijal K, Sontipong S, Sriamporn S, Parkin DM, Ferlay J. eds. Cancer in Thailand 1988-1991 IARC Technical report No. 16 International Agency for Research on Cancer, Lyon France, 1993 ISBN 92 832 1430 7

Tumor registry statistical report 1993. Faculty of medicine. Chulalongkorn hospital. Bangkok. Thailand.

Sickles EA. Mammographic features of 300 consecutive nonpalpable breast cancers. AJR 1986;146:661-3.

Niloff PH, Sheiner NM. False-negative mammograms in patients with breast cancer. Canadian J Surg 1981;24:50-2.

Kopans DB. The positive predictive value of Mammography. AJR 1992;158:521-6.

Abdel Dayem HM, Scott AM, Macapinlac HA, El-Gazzar AH, Larsen SM. Role of 201T1 chloride and 99mTc sestamibi in tumor imaging. In: Freeman LM, ed. Nuclear Medicine Annual 1994. New York, NY: Raven Press: 1994:181-234.

Waxman A, Ashok G, Kooba A, et al. The use of 99mTc-methoxy isobutyl] isonitrile (MIBI) in the evaluation of patients with primary carcinoma of the breast (abstract). Clin Nucle Med 1992;9:761.

Campeau RJ, Kronemer KA, Sutherland CM. Concordant uptake of Tc-99m sestamibi and T1-201 in unsuspected breast tumor. Clin Nucl Med 1992;17:936-7.

Kao CH, Wang SJ, Liu TJ. The use of technetium-99m-methoxyisobutilisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21: 432-6.

Palmedo H, Schomburg A, Grunwald F, Mallmann P, Krebs D, Biersack H. Technetium-99m-MIBI — scintimammography for suspicious breast lesion. J Nucl Med 1996;37:626-30.

Villanueva-Meyer J, Leonard MH_ Jr, Briscoe F, et al. Scintimammography with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996;37:926- 30.

Campeau RJ, Kronemer KA, Sutherland CM Concordant uptake of Tc-99m sestamibi and T1-201 in unsuspected breast tumor. Clin Nucl Med 1992;17(12):936-7

Waxman A, Nagaraj N, Ashok G, etal. Sensitivity and specificity of tc-99m methoxy isonitrile (mibi) in the evaluation of primary-carcinoma of the breast - comparison of palpable and non-palpable lesions with mammography.J Nucl Med 1994;35(5):P22-P22

Suppl. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. EurJ Nucl Med 1994;21(5): 432-6

Khalkhali I, Cutrone J, Menal, et al. Technetium-99m-sestamibi scintimammography of breast-lesions-clinical and pathological follow-up. J Nucl Med 1995; 36(10):1784-9

Palmedo H, Schomburg A, Grunwald F, Mallmann P, Krebs D, Biersack HJ Technetium-99m-MIBI — scintimammography for suspicious breast lesions. J Nucl Med 1996;37(4):626-30

Becherer A, Helbich T, Staudenherz A, Jakesz R, Kubista E, Lehner R, Rudas M, Teleky B, Kletter K, Leitha T. The diagnostic value of planar and SPET scintimammography in different age groups. Nucl Med Commun 1997;18(8): 710-8

Becherer A, Helbich T, Staudenherz A, Jakesz R, Kubista E, Lehner R, Rudas M, Teleky B, Kletter K, Leitha T. The diagnostic value of planar and SPET scintimammography in different age groups. Nucl Med Commun 1997;18(8): 710-8

Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast-lesions-clinical and pathological follow-up. J Nucl Med 1995: 36(10):1784-9

Downloads

Published

2023-04-12

How to Cite

1.
CHAIWATANARAT T, APINYANURAK C, BOONJUNWETWAT D, CHATAMRA K, POSHYACHINDA M. BREAST CANCER DETECTION WITH 99M TC MIBI IMAGING AND MAMMOGRAPHY. ASEAN J Radiol [Internet]. 2023 Apr. 12 [cited 2024 Dec. 9];6(1):73-82. Available from: https://www.asean-journal-radiology.org/index.php/ajr/article/view/520

Issue

Section

Original Article

Most read articles by the same author(s)

1 2 > >>